Pharmaceutical manufacturing, quality, and supply chain management can all benefit from the wise application of artificial intelligence (AI). But what approach should pharma manufacturers take to harnessing AI in these areas? And what are the risks?

To explore these questions, we sat down with Pat Day, a principal consultant at Lachman Consultants. Following more than 25 years working inside the pharmaceutical industry, Pat now serves as a consultant, focusing on areas such as risk management, data integrity and data governance, and supply chain logistics — and now, AI.

We discussed:

• Where AI can offer the most immediate benefits in pharmaceutical manufacturing and quality
• The common mistake corporate leaders make in AI initiatives — and the risks that result (hint: protect your institutional knowledge)